• Home
• Media centre
• Press kits

Press kits

Avandia press kit

Avandia (rosiglitazole maleate) was the subject of a June 2007 edition of the New England Journal of Medicine (NEJM*) about cardiovascular risk.

• Visit the Avandia press kit

Cervarix press kit - 18 July 2007

GSK's cervical cancer candidate vaccine Cervarix receives positive opinion in Europe for prevention of cervical cancer.

• 18 July press release

Background documents (PDF)

• Cervical cancer key facts
• Cervarix - clinical trials information

B-roll

• 27 June B-roll
• 17 April B-roll and sound bites

 

Veramyst press kit - 27 April 2007

GSK announces approval by the US Food and Drug Administration for Veramyst Nasal Spray.

• 27 April press release

Background documents (PDF)

• Veramyst Fact Sheet (PDF 41Kb)
• Nasal Allergy Backgrounder (PDF 33Kb)
• US patient prescribing information
• Veramyst pack shot (JPG 308Kb)

B-roll

• B-roll and sound bites

 

Altabax press kit - 12 April 2007

GSK announces approval by the US Food and Drug Administration for its topical antibacterial, Altabax.

• 12 April press release
  
  

Background documents (PDF)

• Altabax key facts

B-roll

• B-roll and sound bites

 

Tykerb press kit - 13 March 2007

GSK announces the approval by the FDA of Tykerb, a new targeted therapy for advanced or metastatic breast cancer.

• 13 March press release
  
  

Background documents (PDF)

• Breast cancer fact sheet
• Tykerb fact sheet
  

• Glossary of breast cancer terms
• Expansion of Patient Assistance Program

 

Pre-pandemic flu press kit - 5 March 2007

New studies suggest that GSK’s pre-pandemic influenza vaccine can protect against different strains of H5N1.

• 5 March press release
  

Background documents (PDF)

• Avian influenza
• Seasonal influenza
• Flu adjuvant system technology
• GSK Biologicals - influenza vaccines
  

Additional documents (PDF)

• Glossary of terms
• Pre-pandemic and pandemic vaccine use
  

For more information, visit our flu resource centre.

Back to top